Kezar Life Sciences Inc (KZR)

Sector:
HEALTH CARE
Industry:
BIOTECHNOLOGY & LIFE SCIENCES
SIC:
PHARMACEUTICAL PREPARATIONS
CEO:
John Fowler
Employees:
60
4000 SHORELINE COURT, SUITE 300, SOUTH SAN FRANCISCO, CA 94080
650-822-5600

Kezar Life Sciences, Inc. engages in the discovery and development of novel small molecule therapeutics. The company's lead product candidate is KZR-616, a selective immunoproteasome inhibitor that is in Phase 2 clinical trials for various indications, including lupus nephritis, dermatomyositis, and polymyositis.

Data derived from most recent annual or quarterly report
Market Cap 64.915 Million Shares Outstanding72.693 Million Avg 30-day Volume 548.205 Thousand
P/E Ratio0.0 Dividend Yield0.0 EPS-0.25
Price to Revenue0.0 Debt to Equity0.0428 EBITDA-94.874 Million
Price to Book Value0.7643 Operating Margin0.0 Enterprise Value-49.105 Million
Current Ratio17.726 EPS Growth-0.095 Quick Ratio17.223
1 Yr BETA 1.483 52-week High/Low 7.89 / 0.67 Profit Margin0.0
Operating Cash Flow Growth-56.8139 Free Cash Flow to Firm (FCFF) TTM -68.574 Million Free Cash Flow to Equity (FCFE) TTM-65.807 Million
Altman Z-Score1.7705
View SEC Filings from KZR instead.

View recent insider trading info

Kezar Life Sciences Inc YCharts
Yahoo! Finance finviz
SEC Web Site SEC DEF 14A Filings

Funds Holding KZR (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
Click for Additional Filters
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding KZR

Download CSV

Active Schedule 13D and 13G filings

Please sign in first

Recent Filings

Financial Reporting

Ownership

  • 4: filed on 2023-11-09 by KIRK CHRISTOPHER J.
  • 4: filed on 2023-07-26 by WALLACE COURTNEY
  • 4: filed on 2023-07-26 by MORDWINKIN NICHOLAS MICHAEL
  • 4: filed on 2023-07-26 by KLEARMAN MICKI
  • 4: filed on 2023-07-26 by KIRK CHRISTOPHER J.
  • 4: filed on 2023-07-26 by HENIG NOREEN
  • 4: filed on 2023-07-26 by FOWLER JOHN FRANKLIN
  • 4: filed on 2023-07-24 by KIRK CHRISTOPHER J.
  • 4: filed on 2023-06-16 by GARNER ELIZABETH
  • 4: filed on 2023-06-16 by WALLACE COURTNEY

    • Events (8k)

  • 8-K: filed on 2023-11-13:
    Item 2.02: Results of Operations and Financial Condition
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2023-10-27:
    Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
  • 8-K: filed on 2023-10-03:
    Item 2.05: Cost Associated with Exit or Disposal Activities
    Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
    Item 7.01: Regulation FD Disclosure
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2023-09-21:
    Item 1.01: Entry into a Material Definitive Agreement
    Item 8.01: Other Events
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2023-08-11:
    Item 8.01: Other Events
  • 8-K: filed on 2023-08-10:
    Item 2.02: Results of Operations and Financial Condition
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2023-07-26:
    Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
  • 8-K: filed on 2023-06-16:
    Item 3.03: Material Modifications to Rights of Security Holders
    Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
    Item 5.07: Submission of Matters to a Vote of Security Holders
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2023-05-11:
    Item 2.02: Results of Operations and Financial Condition
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2023-04-27:
    Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers

    • Proposed Sales (Form 144)

    Proxy

    Prospectus

    All

    Open Market Buys/Sells Last 60 Days

    Open Market Buys (P)

    none

    Open Market Sells (S)

    none

    Exercise Derivative Conversion (M)

    none

    Current/Former Insiders

    Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

    KIRK CHRISTOPHER J. CEO

    • Officer
    • Director
    		 0 2023-11-08 4

    MORNINGSIDE VENTURE INVESTMENTS LTD

    • 10% Owner
    		 1,947,993 2023-08-15 11

    BERGER FRANKLIN M

    • Director
    		 0 2023-07-24 2

    KAUFFMAN MICHAEL

    • Director
    		 0 2023-07-24 2

    BELSKY MARC CHIEF FINANCIAL OFFICER

    • Officer
    		 0 2023-07-24 2

    COOPER GRAHAM K

    • Director
    		 0 2023-07-24 2

    GARNER ELIZABETH

    • Director
    		 0 2023-07-24 2

    FOWLER JOHN FRANKLIN CEO

    • Officer
    • Director
    		 0 2023-07-24 2

    WALLACE COURTNEY

    • Director
    		 0 2023-07-24 2

    HENIG NOREEN CHIEF MEDICAL OFFICER

    • Officer
    		 0 2023-07-24 2

    KLEARMAN MICKI

    • Director
    		 0 2023-07-24 2

    MORDWINKIN NICHOLAS MICHAEL CHIEF BUSINESS OFFICER

    • Officer
    		 0 2023-07-24 2

    SOMMADOSSI JEAN-PIERRE

    • Director
    		 26,000 2021-06-28 0

    DINGES JASON

    • Director
    		 26,000 2021-06-28 0

    ECONOMIDES VASSILIKI SVP, STRATEGY & EXTERNAL AFF.

    • Officer
    		 0 2021-01-08 0

    EQUAL TALENT INVESTMENTS LTD

    • 10% Owner
    		 6,254,545 2020-06-11 0

    GOEL NITI CHIEF MEDICAL OFFICER

    • Officer
    		 0 2019-01-06 0

    ONYX THERAPEUTICS, INC.

    AMGEN INC

    • 10% Owner
    		 No longer subject to file 2018-06-25 0

    STEYER THOMAS F

    STEYER THOMAS F

    • FORMER 10% OWNERFORMER 10% OWNER
    		 No longer subject to file 2018-06-25 0

    PAPPAS ARTHUR M

    A.M. PAPPAS LIFE SCIENCE VENTURES V, LP

    PV V CEO FUND, LP

    AMP&A MANAGEMENT V, LLC

    PAPPAS CAPITAL, LLC

    • 10% Owner
    		 No longer subject to file 2018-06-25 0

    BAY CITY CAPITAL LLC

    • 10% Owner
    		 No longer subject to file 2018-06-25 0

    OMEGA FUND IV, L.P.

    OMEGA FUND IV GP, L.P.

    OMEGA FUND IV G.P. MANAGER, LTD.

    STAMPACCHIA OTELLO

    LIM RICHARD J.

    PASTER ANNE-MARI

    • FORMER 10% OWNERFORMER 10% OWNERFORMER 10% OWNERFORMER 10% OWNERFORMER 10% OWNERFORMER 10% OWNER
    		 No longer subject to file 2018-06-25 0

    CORMORANT ASSET MANAGEMENT, LP

    CHEN BIHUA

    CORMORANT GLOBAL HEALTHCARE GP, LLC

    CORMORANT GLOBAL HEALTHCARE MASTER FUND, LP

    • Director
    • 10% Owner
    		 No longer subject to file 2018-06-25 0

    ABERDARE MANAGEMENT COMPANY, LLC

    • 10% Owner
    		 No longer subject to file 2018-06-25 0

    CHIESI VENTURES, INC.

    CHIESI VENTURES, LP

    CHIESI GIACOMO

    • 10% Owner
    		 No longer subject to file 2018-06-25 0

    STEYER THOMAS F

    • 10% Owner
    		 0 2018-06-20 0

    CORMORANT ASSET MANAGEMENT, LP

    CORMORANT GLOBAL HEALTHCARE MASTER FUND, LP

    CORMORANT PRIVATE HEALTHCARE FUND I, LP

    CHEN BIHUA

    • Director
    • 10% Owner
    		 0 2018-06-20 0

    Insider Transactions Last 60 Days

    Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
    Disposed    		 Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days

    KIRK CHRISTOPHER J. - Director - Officer CEO

    		2023-11-09 16:25:13 -0500 2023-11-08 A 875,000 a 875,000 direct

    * -

    Transaction Code Definitions
    Code Definition
    A Grant, award or other acquisition pursuant to Rule 16b-3(d)
    C Conversion of derivative security
    D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
    E Expiration of short derivative position
    F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
    G Bona fide gift
    H Expiration (or cancellation) of long derivative position with value received
    I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
    J Other acquisition or disposition
    L Small acquisition under Rule 16a-6
    M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
    O Exercise of out-of-the-money derivative security
    P Open market or private purchase of non-derivative or derivative security
    S Open market or private sale of non-derivative or derivative security
    U Disposition pursuant to a tender of shares in a change of control transaction
    W Acquisition or disposition by will or the laws of descent and distribution
    X Exercise of in-the-money or at-the-money derivative security
    Z Deposit into or withdrawal from voting trust

    IBR Securities Loan Availability

    Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers

    Security Date/Time Rebate Rate Fee Rate Shares Available
    KEZAR LIFE SCIENCES INC KZR 2023-11-27 22:15:04 UTC 4.6068 0.7132 400000
    KEZAR LIFE SCIENCES INC KZR 2023-11-27 21:45:04 UTC 4.6068 0.7132 400000
    KEZAR LIFE SCIENCES INC KZR 2023-11-27 21:15:03 UTC 4.6068 0.7132 400000
    KEZAR LIFE SCIENCES INC KZR 2023-11-27 20:45:04 UTC 4.6068 0.7132 400000
    KEZAR LIFE SCIENCES INC KZR 2023-11-27 20:15:05 UTC 4.6107 0.7093 400000
    KEZAR LIFE SCIENCES INC KZR 2023-11-27 19:45:04 UTC 4.6107 0.7093 400000
    KEZAR LIFE SCIENCES INC KZR 2023-11-27 19:15:04 UTC 4.6107 0.7093 400000
    KEZAR LIFE SCIENCES INC KZR 2023-11-27 18:45:05 UTC 4.6107 0.7093 400000
    KEZAR LIFE SCIENCES INC KZR 2023-11-27 18:15:03 UTC 4.6107 0.7093 400000
    KEZAR LIFE SCIENCES INC KZR 2023-11-27 17:45:04 UTC 4.5471 0.7729 400000
    KEZAR LIFE SCIENCES INC KZR 2023-11-27 17:15:03 UTC 4.5471 0.7729 400000
    KEZAR LIFE SCIENCES INC KZR 2023-11-27 16:45:04 UTC 4.5471 0.7729 400000
    KEZAR LIFE SCIENCES INC KZR 2023-11-27 16:15:03 UTC 4.5471 0.7729 400000
    KEZAR LIFE SCIENCES INC KZR 2023-11-27 15:45:04 UTC 4.5471 0.7729 400000
    KEZAR LIFE SCIENCES INC KZR 2023-11-27 15:15:03 UTC 4.5471 0.7729 400000
    KEZAR LIFE SCIENCES INC KZR 2023-11-27 14:45:03 UTC 4.5603 0.7597 400000
    KEZAR LIFE SCIENCES INC KZR 2023-11-27 14:15:04 UTC 4.5603 0.7597 200000
    KEZAR LIFE SCIENCES INC KZR 2023-11-27 13:45:04 UTC 4.5647 0.7553 200000
    KEZAR LIFE SCIENCES INC KZR 2023-11-27 13:15:04 UTC 4.5647 0.7553 200000
    KEZAR LIFE SCIENCES INC KZR 2023-11-27 12:45:04 UTC 4.5647 0.7553 200000

    Current Active Short Positions

    Holder Issuer Net Short Position Position Date Origin

    No recent transactions

    *** To see all congressional transactions (since 2022) for this stock, please use the congressional transaction search page***

    WhaleWisdom Logo

    Elevate your investments